POZIMPRA Trademark

Trademark Overview


On Friday, August 26, 2016, a trademark application was filed for POZIMPRA with the United States Patent and Trademark Office. The USPTO has given the POZIMPRA trademark a serial number of 79194625. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 29, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The POZIMPRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
pozimpra

General Information


Serial Number79194625
Word MarkPOZIMPRA
Filing DateFriday, August 26, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 29, 2023
Registration Number5158577
Registration DateTuesday, March 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events


Event DateEvent Description
Tuesday, November 8, 2016APPLICATION FILING RECEIPT MAILED
Monday, November 14, 2016ASSIGNED TO EXAMINER
Saturday, November 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2016NOTICE OF PUBLICATION
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Friday, May 5, 2017NOTIFICATION PROCESSED BY IB
Friday, September 29, 2023CANCELLED SECTION 71
Thursday, June 27, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 27, 2024INVALIDATION PROCESSED
Thursday, October 27, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, November 2, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 3, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, April 14, 2017FINAL DISPOSITION PROCESSED
Friday, April 14, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, July 20, 2024TOTAL INVALIDATION PROCESSED BY THE IB